reference/5819399

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5819399

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	2307
issn	0028-4793 1533-4406
issueIdentifier	22
pageRange	2297-2307
publicationName	The New England journal of medicine
startingPage	2297
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_799f060c0e9635478f7760bc92eb539f
bibliographicCitation	Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med. 2006 Nov 30;355(22):2297–307. doi: 10.1056/nejmoa060326. PMID: 17135584.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da930a520d9393b9e9734511837f2afa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b33b2ec26307d9a7cc0c0f9f31490b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7860187c3433fc85852f272d43b99037 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_235ae2fa9afa2061b3068375c460d382 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3b374ec0a8c00ca85aa889984659f86 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b4f5c715c51afc2d2f20b1a516f4fd1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3247e9cb00d619047480e12ece419e00 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9bb9d4dc3c7f683667e7532573c903d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93a566cb8b25c146fbac5234d76f28d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6294b2e33e84484d69128e993a4f341 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0742d15bcaacfc51124c767da63ec607 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73e67c39a5f66ef2431d774bd15b3f90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cec2ea206675b1b02ab9c3a2b7fbe490 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_432f5bd52c6c29f87541268cfce3f36b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a875e6af7d806b36d65a9a0b2e2d88e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b27eeb961e6b560f65e7e4a64c894e1b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_704d5ca1f815f0afb32255629859e6cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa35b3b5d05dfb171c0c41fd21ee05c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f44c5f7b3b08629966d842f2a74ecc1
date	2006-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1056/nejmoa060326 https://pubmed.ncbi.nlm.nih.gov/17135584
isPartOf	https://portal.issn.org/resource/ISSN/0028-4793 https://portal.issn.org/resource/ISSN/1533-4406 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5985
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
discusses	http://id.nlm.nih.gov/mesh/M0168845 http://id.nlm.nih.gov/mesh/M0447306 http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0002696 http://id.nlm.nih.gov/mesh/M0011417
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D045162Q000627 http://id.nlm.nih.gov/mesh/D005234Q000178 http://id.nlm.nih.gov/mesh/D007004Q000627 http://id.nlm.nih.gov/mesh/D005234Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D018149Q000188 http://id.nlm.nih.gov/mesh/D003924Q000150 http://id.nlm.nih.gov/mesh/D008099Q000473 http://id.nlm.nih.gov/mesh/D005234Q000473 http://id.nlm.nih.gov/mesh/D001786Q000378 http://id.nlm.nih.gov/mesh/D018149Q000178 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006505Q000188 http://id.nlm.nih.gov/mesh/D001786Q000187 http://id.nlm.nih.gov/mesh/D008103Q000473 http://id.nlm.nih.gov/mesh/D007328Q000097 http://id.nlm.nih.gov/mesh/D000077205 http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D003924Q000178 http://id.nlm.nih.gov/mesh/D006505Q000178 http://id.nlm.nih.gov/mesh/D031204 http://id.nlm.nih.gov/mesh/D007333 http://id.nlm.nih.gov/mesh/D009336 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D005234Q000150
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5437 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11475 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8596 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8179 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10098 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107526 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10435 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4829 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7708 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.6.1.1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7739 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7548

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128240590 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128635168 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127796644 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127638306 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433

Total number of triples: 97.